Laddar...
Molecularly targeted therapies for p53-mutant cancers
The tumor suppressor p53 is lost or mutated in approximately half of human cancers. Mutant p53 not only loses its anti-tumor transcriptional activity, but also often acquires oncogenic functions to promote tumor proliferation, invasion, and drug resistance. Traditional strategies have been taken to...
Sparad:
| I publikationen: | Cell Mol Life Sci |
|---|---|
| Huvudupphovsmän: | , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Springer International Publishing
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5664959/ https://ncbi.nlm.nih.gov/pubmed/28643165 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00018-017-2575-0 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|